 Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores
Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore
Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore
LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects
NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects Lemon Tree Hotels signs 11th property in Punjab
Lemon Tree Hotels signs 11th property in Punjab 
              The Union Cabinet today gave its approval to the establishment of National Institute of Biomedical Genomics ( (NIBMG) at Kalyani in Nadia District of West Bengal as an autonomous institution under the aegis of Department of Biotechnology, Ministry of Science & Technology with the budgetary provision of rs.210 crores. The institute will be a society registered under the Societies Registration Act, and will be governed by the Governing Body.
The Institute has emphasis towards enhancement of knowledge on human health & disease through genomics and translate the knowledge using appropriate technologies for promotion of well being and improvement of genomics-based health-care in India.
NIBMG will create necessary physical infrastructure and build capacity to serve as the expert base for the establishment of principles and practice of biomedical genomics and promote cutting-edge research in biomedical genomics for better understanding and reduction of public-health burden in India. The grand vision is to provide personalised, predictive, preventive and therapeutic healthcare through the use of genomic knowledge.
NIBMG will usher in the genomics era explicitly in the areas of medicine and public-health. It will undertake novel research, translational, educational & training programmes, network with relevant institutions through star alliance, and seed biomedical genomics activities in hospitals, medical school and other health-care institutions.